Data quality, quantity, and privacy are challenges for learning models in thrombosis. These emerging tools require more trained staff and patient input to become established in clinical practice.
Monoclonal antibodies are the best option against SARS-CoV-2 for oncohematology patients, although viral variants may reduce the efficacy of these treatments.
Outcomes may improve by combining different treatment options, but the type of scar drives the type of modality to consider, according to Dr Arisa Ortiz of UC San Diego.